SPONSOR
Tang-Du Hospital
Total Trials
4
Recruiting
4
Phases
Phase 4, Phase 2
Tang-Du Hospital is a clinical research sponsor with 4 registered studies on ClinicalTrials.gov, of which 4 are actively recruiting participants. Research covers conditions including Small Cell Lung Cancer, Healthy Adult Brain Imaging, Lung Cancer, SCLC.
The trial portfolio spans Phase 4, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Tang-Du Hospital
How many clinical trials has Tang-Du Hospital sponsored?
ClinicalMetric currently tracks 4 clinical trials sponsored by Tang-Du Hospital, of which 4 are actively recruiting participants. These trials cover conditions including Small Cell Lung Cancer, Healthy Adult Brain Imaging, Lung Cancer. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Tang-Du Hospital research focus on?
Tang-Du Hospital clinical trials span Small Cell Lung Cancer, Healthy Adult Brain Imaging, Lung Cancer, SCLC. The research pipeline includes Phase 4, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Tang-Du Hospital clinical trial?
To participate in a Tang-Du Hospital trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Tang-Du Hospital trials with current recruitment status updated daily.
Clinical Trials by Tang-Du Hospital
NCT06467786 Phase 4
Recruiting
Study on the Therapeutic Effect of Irinotecan Liposomes in Small Cell Lung Cancer
Small Cell Lung Cancer
NCT07786233
Recruiting
Multi-Field-Strength MRI Brain Atlas Construction in Healthy Chinese Population
Healthy Adult Brain Imaging
NCT06644066
Recruiting
Partial Pressure of Oxygen Control Method in Identification of Intersegmental Plane
Lung Cancer
NCT06475209 Phase 2
Recruiting
Adebrelimab + Apatinib in SCLC Maintenance Therapy
SCLC
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology